Kenn Massesson
Associate Product Director – GMA Digital Transformation at Novo Nordisk | Copenhagen, Capital Region of Denmark, Denmark
Kenn Massesson’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Associate Product Director – GMA Digital Transformation at Novo Nordisk in August 2025 - Present
Data & Digitalisation Lead — Digital transformation GMA at Novo Nordisk in August 2023 - August 2025
Product Strategy & Innovation consultant at Massesson Consulting in April 2023 - August 2023
Strategy Lead at Work & Co in April 2022 - April 2023
Associate Strategy Director at AKQA in April 2021 - April 2022
Senior Strategist at AKQA in June 2020 - April 2021
Strategist at AKQA in April 2018 - June 2020
Innovation Consultant, New Ventures at MobilePay in October 2017 - March 2018
Innovation Consultant, MobilePay Concepts at MobilePay in March 2016 - October 2017
Freelance UX & Strategy Consultant at Massesson Consulting in March 2014 - February 2016
Freelance planner at AKQA in March 2015 - July 2015
Information / UX Architect at Gorm Larsen & Zornig in December 2012 - June 2014
Student employee; Information architecture and communications at Inventio.IT A/S in August 2012 - December 2012
Sales Assistant at Goods in February 2010 - June 2012
Retail Sales Assistant at adidas in October 2008 - January 2010
Hyper Island, Master of Arts (MA) Digital Media Management, July 2026
DTU - Technical University of Denmark, Master level courses, July 2026
Roskilde University, Bachelor of Science (BSc), July 2026
We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health. Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 68,800 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to block and remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html
Discover more about Novo Nordisk
Global Director Frontline Excellence Rare Diseases, Novo Nordisk
Owner at Veum Consulting
(March 2015 – Present)
PMP® | Regulatory Affairs Project Lead (Business Area Middle East, Affrica & CIS) at Novo Nordisk
Regulatory Affairs Project Lead (Business Area Middle East, Africa &CIS) at Novo Nordisk
(January 2024 – Present)
Medical Science Liaison, Diabetes & Renal
Wine Rep at ONEHOPE Wine
(June 2021 – Present)
Public Affairs Manager presso Novo Nordisk
Public Affairs Manager at Novo Nordisk
(May 2022 – Present)
Obesity Market Access | Novo Nordisk Canada
Consultant at Global Market Access Solutions
(May 2026 – May 2026)
Associate Director – Novo Nordisk
Student in Business Partner Operation Nordic (BPO) at IBM
(January 2006 – May 2026)
What is Kenn Massesson email address?
Email Kenn Massesson at [email protected] and [email protected]. This email is the most updated Kenn Massesson's email found in 2026.
What is Kenn Massesson phone number?
Kenn Massesson phone number is 918046771000.
How to contact Kenn Massesson?
To contact Kenn Massesson send an email to [email protected] or [email protected]. If you want to call Kenn Massesson try calling on 918046771000. (updated on April 24, 2026)
What company does Kenn Massesson work for?
Kenn Massesson works for Novo Nordisk.
What is Kenn Massesson's role at Novo Nordisk?
Kenn Massesson is Associate Product Director – GMA Digital Transformation
What industry does Kenn Massesson work in?
Kenn Massesson works in the Pharmaceuticals industry.
